Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q2 2023)

As of Jun 30, 2023, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 11, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2023, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q2 2023
64132K201
NeuBase Therapeutics
Buy - Position Entry
+12,601
Q2 2023
A
Agilent Technologies, Inc.
Sell
-212,400
Q2 2023
AA
Alcoa Corporation
Sell
-37,796
Q2 2023
AAAU
Goldman Sachs Physical Gold ETF
Sell - Position Exit
-94,400
Q2 2023
AADI
Aadi Bioscience, Inc.
Sell
-121,602
Q2 2023
AAL
American Airlines Group, Inc.
Buy
+1,384,800
Q2 2023
Sell - Position Exit
-9,785
Q2 2023
AAME
Atlantic American Corporation
Buy
+800
Q2 2023
AAN
Sell
-163,000
Q2 2023
AAOI
Applied Optoelectronics, Inc.
Buy
+68,100
Q2 2023
AAON
AAON, Inc.
Buy
+4,800
Q2 2023
AAP
Advance Auto Parts Inc.
Buy
+378,831
Q2 2023
AAPL
Apple Inc.
Buy
+4,912,234
Q2 2023
AAT
American Assets Trust, Inc.
Sell - Position Exit
-56,500
Q2 2023
AAXJ
iShares MSCI All Country Asia e
Buy
+16,200
Q2 2023
ABBNY
ABB Ltd.
Sell - Position Exit
-305,700
Q2 2023
ABBV
AbbVie Inc.
Buy
+964,212
Q2 2023
ABCB
Ameris Bancorp
Buy - Position Entry
+19,769
Q2 2023
ABCL
AbCellera Biologics Inc.
Sell
-274,900
Q2 2023
ABEO
Abeona Therapeutics Inc.
Sell
-3,300
Q2 2023
ABEV
Ambev S.A.
Sell
-374,030
Q2 2023
ABG
Asbury Automotive Group Inc
Sell - Position Exit
-19,800
Q2 2023
Buy
+4,800
Q2 2023
ABM
ABM Industries Incorporated
Sell
-200
Q2 2023
ABNB
Airbnb, Inc.
Sell
-760,029
Q2 2023
ABOS
Acumen Pharmaceuticals, Inc.
Buy
+7,355
Q2 2023
ABSI
Absci Corporation
Buy
+166,475
Q2 2023
ABT
Abbott Laboratories
Sell
-3,561,997
Q2 2023
ABUS
Arbutus Biopharma Corporation
Buy
+46,137
Q2 2023
AC
Associated Capital Group, Inc.
Buy
+600
Page 1 of 119